Overgenes

What Overgenes does

Overgenes S.L. is a privately held Spanish precision genetics company headquartered at the Parc Científic de la Universitat de València in Paterna, Valencia. The company operates a B2B2C model that sells genetic, microbiota, and epigenetic testing services through two channels: a direct-to-consumer online storefront (https://overgenes.com/tienda/) shipping saliva-based kits to consumers' homes, and a professional collaboration program providing clinics and healthcare professionals (physicians, pharmacists, nutritionists, sports medicine specialists) with genetic testing capabilities, sample processing, and clinical reports. Its portfolio comprises 19 specialized tests organized into actionable genetics, preventive genetics, precision genetics (pharmacogenetics), epigenetics, and microbiota categories, with results delivered within 20 business days to a secure private client portal.

The technical core is the proprietary AIG (Automated Intelligence Genetics) platform, which integrates data mining, machine learning algorithms, and major scientific databases (PubMed, ClinVar, GWASCatalog, PharmGKB) to apply ACMG/AMP criteria and polygenic risk scoring across more than 12.5 million genetic variants per test, using Illumina GSA Orion high-throughput genotyping and HL7 integration for health system interoperability. The company operates a Professional Collaboration Program with a multi-channel marketing approach (content/SEO, social media, conferences, healthcare professional referrals) and pursues ISO 13485 and CE-IVDR certifications to support clinical-grade sales.

Overgenes generates revenue primarily through one-time per-test purchases (genetic tests are conducted once in a lifetime) and recurring test volume through professional/clinical partners, with volume discounts of 25–40% on multi-test bundles. The company has no disclosed institutional equity funding; its growth has been supported through Spanish and EU non-dilutive grants from CDTI (including Neotec), IVACE, ICEX Next, and NextGenerationEU/FEDER programs, and it has established validation and clinical partnerships with entities including Eurofins Genomics, Fisabio, INCLIVA, Hospital del Mar, Hospital Sant Pau, Hospital Clínic de Barcelona, and Ribera Salud.

Name

Overgenes

Legal name

Overgenes S.L.

Website

https://overgenes.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Direct-to-Consumer Genetic Testing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAAALAD

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAFAMAH

Genetic & Prenatal Testing Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAFAMAE

Molecular Diagnostics & Genomics Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

Keywords

• Genetic testing services
• Precision medicine diagnostics
• Pharmacogenetic analysis
• Epigenetic age testing
• Microbiome diagnostics

Headquarters

HQ city

Paterna

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Genetic and Epigenetic Testing Kits: Overgenes sells individual genetic, microbiota, and epigenetic test kits directly to consumers and healthcare professionals. Each test is a one-time purchase (conducted once in a lifetime as genetics do not change). Tests are ordered online, a saliva kit is shipped to the customer's home, and a personalized report is delivered digitally within 20 business days. Volume discounts apply: 25% off for 2 tests, 30% for 3, 35% for 4, and 40% for 5+ (for the same person).
2. Professional Collaboration Program: Overgenes offers a professional collaboration program for healthcare professionals and clinics, providing them with genetic testing capabilities, materials, sample processing, a digital platform, and clinical reports. This B2B channel generates revenue through professional orders and recurring test volume from partner clinics.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

Overgenes sells 19 specialized genetic, microbiota, and epigenetic tests (including actionable genetics, preventive genetics, pharmacogenetics, epigenetics, and microbiota categories) delivered via saliva sample collection and analyzed on its proprietary AIG platform, which evaluates over 12.5 million genetic variants using machine learning and reference scientific databases to generate personalized clinical reports within 20 business days. The company sells these tests directly to consumers through its online store and to healthcare professionals and clinics through a B2B Professional Collaboration Program.

Product overview

Overgenes offers a comprehensive genetic testing portfolio centered on its proprietary AIG (Automated Intelligence Genetics) platform. The product suite spans three main categories: Actionable Genetics (Myi4, MyDiet, MySport, MySupplements, MyDetox, MyFolate, MyAgeing, MyInflammation, MyNeuro, MyEstrogen) for personalized health interventions; Preventive Genetics (MyPrevention Cardio, MyPrevention Diabetes, MyPrevention Sarcopenia) for disease risk assessment; and Precision Genetics including pharmacogenetic tests (MyPharma, MyPharma Pain, MyPharma Neuro, MyPharma Onco) covering 120+ medications across pain, neuropsychiatry, and oncology. The portfolio also includes epigenetic testing (MyEpiAgeing) based on ELOVL2 DNA methylation clock, and metagenomic gut microbiota analysis. All tests use saliva samples with results delivered within 20 business days via a private client portal, processing over 12.5 million genetic variants per analysis.

Differentiator

Problem solved

Functional benefit

Products and services

• Myi4 Genetic intolerance test analyzing lactose, gluten, fructose and histamine intolerances based on individual genetic variants, designed for consumers and clinicians seeking personalized dietary guidance.
• MyDiet Nutrigenetic test profile for personalizing diet based on genetic makeup, enabling tailored nutritional recommendations for individuals and patients.
• MySport Sports performance genetic test analyzing athletic performance factors and nutrition adaptation, providing personalized sports and exercise recommendations.
• MySupplements Genetic analysis of supplements and vitamins needs based on individual genetic variants, providing personalized supplementation recommendations.
• MyDetox Hepatic detoxification genetic test analyzing Phase I and Phase II liver detoxification capacity for personalized detox and lifestyle recommendations.
• MyFolate Folate metabolism genetic test analyzing folate processing pathways to deliver personalized nutritional and supplementation guidance.
• MyAgeing Healthy aging longevity genetic profile analyzing genetic markers associated with aging processes for personalized longevity and lifestyle planning.
• MyInflammation Inflammation and oxidative stress genetic profile analyzing inflammatory response and oxidative stress markers to guide personalized interventions.
• MyNeuro Neurotransmitter genetic test analyzing neuronal processes, brain function, and mood-related genetic variants for personalized mental-wellness insights.
• MyEstrogen Estrogen metabolism genetic test analyzing estrogen processing and hormonal-health genetic factors for personalized hormonal and lifestyle guidance.
• MyPrevention Cardio Cardiovascular genetic prevention test analyzing genetic variants associated with cardiovascular disease risk for personalized prevention strategies.
• MyPrevention Diabetes Diabetes genetic prevention test analyzing Type I, Type II, and MODY diabetes genetic variants together with relevant pharmacogenetics.
• MyPrevention Sarcopenia Sarcopenia predisposition genetic test analyzing genetic factors associated with muscle mass loss to inform prevention and intervention strategies.
• MyPharma General pharmacogenetic test analyzing genetic variants affecting patient response to over 120 commonly used medications across therapeutic areas.
• MyPharma Pain Chronic pain pharmacogenetic test analyzing genetic variants affecting patient response to 73 pain management medications.
• MyPharma Neuro Neuropsychiatry pharmacogenetic test analyzing genetic variants affecting response to 70+ mental health medications.
• MyPharma Onco Oncology pharmacogenetic test analyzing genetic variants affecting response to 25 cancer treatment medications.
• MyEpiAgeing Epigenetic biological age clock test based on DNA methylation patterns in the ELOVL2 gene promoter region, enabling tracking of biological age changes after clinical interventions or lifestyle improvements.
• Microbiota Intestinal Intestinal microbiota metagenomic test analyzing gut microbiome composition for personalized health, nutrition, and gut-health recommendations.
• Professional Collaboration Program B2B collaboration program providing healthcare professionals and clinics with Overgenes' genetic testing capabilities, materials, sample processing, a digital platform, and clinical reports for integration into their practice.

Quantifiable outcome

• 19 specialized tests available across genetics, microbiota, and epigenetics
• +4 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature6 records

Partnerships

13 partnerships are on record, tiered core and minor.

• FisabiocoreStrategic or Co-development PartnerFisabio (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana) partners with Overgenes for innovation, validation, and improvement of products, facilitating knowledge transfer and developing precision medicine solutions.
• Universitat de ValènciacoreStrategic or Co-development PartnerOvergenes is located at the Parc Cientific University of Valencia and collaborates with the university on research, validation, and development of precision medicine solutions. Several advisory team members are professors at the university.
• INCLIVAcoreStrategic or Co-development PartnerINCLIVA (Instituto de Investigación Sanitária del Hospital Clínico Universitario de Valencia) collaborates with Overgenes on clinical research and precision medicine validation projects.
• Hospital del MarcoreStrategic or Co-development PartnerHospital del Mar collaborates with Overgenes for innovation, product validation, and development of precision medicine solutions.
• Hospital Sant PaucoreStrategic or Co-development PartnerHospital Sant Pau (Barcelona) partners with Overgenes for clinical research and precision medicine validation.
• Eurofins GenomicscoreTechnology or IntegrationEurofins Genomics is a partner providing genomics laboratory services that support Overgenes' genetic testing operations.
• Universidad Autónoma de Madrid (UAM)coreStrategic or Co-development PartnerUAM collaborates with Overgenes on innovation, knowledge transfer, and precision medicine development.
• Universitat Politècnica de València (UPV)coreStrategic or Co-development PartnerUPV partners with Overgenes for innovation, validation, and development of precision medicine solutions.
• UCAM (Universidad Católica San Antonio de Murcia)minorStrategic or Co-development PartnerUCAM collaborates with Overgenes on innovation and development of precision medicine solutions.
• CEU San Pablo UniversidadminorStrategic or Co-development PartnerCEU San Pablo Universidad partners with Overgenes for innovation and precision medicine development.
• Hospital Clínic de BarcelonacoreStrategic or Co-development PartnerHospital Clínic de Barcelona collaborates with Overgenes on clinical research and precision medicine solutions.
• Ribera SaludminorStrategic or Co-development PartnerRibera Salud partners with Overgenes for innovation and precision medicine development.
• IlluminacoreTechnology or IntegrationOvergenes uses Illumina GSA Orion genotyping technology for high-throughput genetic analysis. Illumina GSA designation indicates a technology partnership for genetic analysis platforms.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Geneplanet: Slovenia-based European genetic testing company offering DTC and B2B nutrigenetic, pharmacogenetic, and wellness tests across Europe. Closest pan-European peer by go-to-market (DTC + clinician channel), test portfolio (nutrition, sport, pharma), and multi-country European footprint.
• DNAfit: UK-based fitness and nutrition genetic testing company sold through both DTC and professional channels (gyms, nutritionists, sports performance coaches). Directly comparable to Overgenes' MySport, MyDiet, and MySupplements products and its B2B professional collaboration model.
• Atlas Biomed: UK-based DTC genetics and gut microbiome testing company. Directly comparable for its combined genetic + microbiota offering, saliva-based workflow, and European consumer-direct go-to-market positioning against Overgenes' Microbiobiota Intestinal and genetic tests.
• EasyDNA: Switzerland-headquartered global DTC genetic testing company with a broad test catalog and international e-commerce presence. Comparable as a multi-country DTC genetic testing operator with similar breadth (health, nutrition, pharmacogenetics) to Overgenes' 19-test catalog.
• Viome Life Sciences: US-based gut microbiome and precision nutrition testing company with subscription-style recurring test revenue. Comparable to Overgenes' microbiota offering and its push toward multi-omic (microbiota + genetic) recommendations, though Viome operates at significantly larger scale.
• Igenomix: Spain-headquartered clinical genetics laboratory focused on reproductive and precision medicine genetic testing. Most directly comparable peer given shared geography (Spain/Valencia ecosystem), B2B2C clinical lab model, and genetic testing portfolio serving clinicians and patients.

Emerging players

• Mapmygenome: India-based genomics company offering DTC and clinician-facing preventive, predictive, and pharmacogenetic tests. Comparable emerging player with a similar preventive + pharmacogenetics + lifestyle test portfolio targeting clinicians and health-conscious consumers.

Broad incumbents

• MyHeritage: Israel-headquartered consumer genetics and ancestry platform with strong European presence. Comparable as a broad incumbent in DTC genetic testing with multi-country European marketing operations overlapping Overgenes' target geographies.
• 23andMe: Largest consumer genetic testing brand globally, offering health, ancestry, and pharmacogenetic reports. A broad incumbent in DTC genetic testing whose reports, marketing scale, and database size set the consumer benchmark that Overgenes competes against in nutrigenetics and pharmacogenetics.

Regional players

• Genera (Dasa): Brazil-based clinical genetics laboratory offering preventive and pharmacogenetic testing to clinicians and consumers across Latin America. Comparable as a regional player in Portuguese-speaking Latin American markets that Overgenes is targeting through its São Paulo congress and EU internationalization activities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/overgenes
• Facebookfacebook.com/overgenes
• LinkedInlinkedin.com/company/overgenes-sl

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Overgenes